NPS Pharmaceuticals (NPSP)

[ThatBobGuy]

Possible Buyout??

Shares of NPS Pharmaceuticals, a biopharmaceutical company focused on developing therapies to treat rare diseases, skyrocketed as much as 26% after rumors surfaced that it could be the target of a buyout.

According to a report from FT Alphaville, which cited familiar sources, Shire (NASDAQ: SHPG) has held internal talks and has been working with its advisors to possible arrange an all-cash offer for NPS Pharmaceuticals of around $40 per share. If Financial Times' blog is accurate, it would represent a valuation in excess of $4 billion for NPS and place a premium of roughly 50% on the company compared to yesterday's closing price. As of this writing, no comment has been issued by either Shire or NPS concerning the matter

Well, the stock sure jumped today...